Virtual health care not living up to full potential, study suggests

17% of Canadians lack a primary care physician; a qualitative study interviewing 25 health professionals across Alberta, Ontario and Nova Scotia finds virtual care is largely phone-based and has not meaningfully freed up physician time or expanded access. Current fee-for-service billing rules that require in-person 'whites of the eyes' create financial incentives for face-to-face visits, limiting productivity gains, though Alberta pilots and a new compensation model encouraging after-hours uptake show some early behavioral shifts. Respondents note improved convenience and patient satisfaction for follow-ups, but material improvement will require team-based care models, broader use of video/secure messaging, and payment reform.

Analysis

The core investable implication is not whether telemedicine exists but who captures the marginal dollar as in-person visits morph into hybrid workflows. If clinics can shift 20–40% of routine touchpoints to asynchronous messaging, protocolized nurse visits and remote monitoring over 2–4 years, physician FTE demand growth slows while platform and device vendors capture recurring revenue — that re-allocates margin away from fee-for-service physician billing into software/subscription and device-consumption streams.

Competitive dynamics will bifurcate between vertically integrated care owners (insurers, retail-health operators) that can internalize triage and chronic care, and horizontal technology providers that monetize workflow integration (secure messaging, RPM ingestion, clinician scheduling). Pure-play telehealth front-door players are exposed to margin compression unless they move downstream into chronic care management or embed payor contracts; conversely, cloud and EHR integrators enjoy sticky enterprise deals and cross-sell optionality.

Key catalysts are reimbursement redesign and labor-scope changes — both binary at a provincial/ state level and lumpy in timing. Expect measurable shifts in utilization mix in pilots inside 6–18 months, but durable unit-economics change only after 18–36 months of contracting and clinician workflow retooling. The contrarian takeaway: telehealth adoption is necessary but not sufficient — investor returns hinge on capture mechanisms (subscription, RPM billables, risk contracts), not visit volume alone.

Key Decisions for Investors

• Long MSFT (12–36 months): Buy the platform play. Microsoft Teams/Azure is strategically positioned to white‑label secure communications and integrate RPM data into EHR workflows; target asymmetric upside of 20–35% vs a 10–15% downside if enterprise cloud competition accelerates. Entry: tranche into weakness around 5–10% pullbacks.
• Pair trade — Long UNH / Short TDOC (12–24 months): Favor integrated payor/provider models that can internalize triage and chronic care (UNH) and short standalone telehealth that faces margin squeeze (TDOC). Risk/reward: UNH upside 15–25% on improved cost per member economics; TDOC downside 25–40% if reimbursement compresses and commercial contracts reprice. Use equal notional sizes and hedge with 3–6 month put protection on the short.
• Long AMN (6–18 months): Increase exposure to flexible clinician staffing and triage workforce providers that will monetize redistributed care tasks. Expect 15–30% upside if demand for mid‑level clinicians and virtual triage grows, with a 12–15% downside risk from macro hiring slowdowns. Consider 9–12 month call spreads to cap cost.
• Long DXCM or ABT (12–36 months): Buy remote-monitoring leaders where device consumables and data subscriptions become the monetization path for chronic disease management; view potential upside 20–40% contingent on RPM reimbursement expansion, downside 15% if adoption lags. Stagger entries with catalysts (pilot results, reimbursement announcements) and size as a thematic allocation not core position.